Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 1685 of 6351
-
New DNA reader aims to solve mystery of undiagnosed ataxia cases
Knowledge-focused Recruiting nowCerebellar ataxias are a group of rare neurological disorders that are clinically and genetically heterogeneous, with several hundred genes and diseases known to date. Over the last decade, their diagnosis has been revolutionised by the development of high-throughput sequencing t…
Sponsor: Centre Hospitalier Universitaire Dijon • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:13 UTC
-
New eye injection aims to slow blindness in rare genetic disease
Disease control OngoingThe purpose of this Phase 2b study is to evaluate the safety and tolerability of ultevursen administered via intravitreal injection (IVT) in subjects with Retinitis Pigmentosa (RP) due to mutations in exon 13 of the USH2A gene. This is a multicenter Double-masked, Randomized, Sha…
Phase 2 • Sponsor: Laboratoires Thea • Aim: Disease control
Last updated Jul 11, 2026 00:00 UTC
-
Experimental antibody trio takes on Hard-to-Treat melanoma
Disease control OngoingWhy the research is needed: Researchers are looking for a better way to treat melanoma that has spread or cannot be removed surgically. Melanoma is a type of skin cancer that starts in melanocytes, the cells that make the pigment that gives skin its color. In people with cancer, …
Phase 1/2 • Sponsor: BioInvent International AB • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC
-
New drug shows promise against rare liver infection
Disease control OngoingThe goal of this clinical trial is to evaluate the efficacy and safety of L47 in the treatment of chronic hepatitis D. Patients with compensated CHD who satisfy the eligibility criteria are stratified by the presence or absence of liver cirrhosis and randomized into three groups …
Phase 2 • Sponsor: Shanghai HEP Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 08:06 UTC
-
App aims to prevent pregnancy-related deaths in minority women
Knowledge-focused CompletedPregnancy-related death is a growing public health issues, which are of particular concern to minority groups, including African-Americans and Spanish-speaking Latinas. Our proposal aims to improve a patient's ability to detect warning signs of pregnancy related death and seek me…
Sponsor: Columbia University • Aim: Knowledge-focused
Last updated Jul 12, 2026 00:00 UTC
-
Blood test may let some lymphoma patients skip late chemo rounds
Knowledge-focused Recruiting nowThe purpose of this study is to 1) determine whether it is feasible to measure circulating tumor DNA (ctDNA) in real-time during standard treatment for newly diagnosed diffuse large B-cell lymphoma (DLBCL), and 2) evaluate the outcomes of participants with undetectable ctDNA in t…
Sponsor: Hua-Jay J Cherng, MD • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:13 UTC
-
New drug combo could tame autoimmune hepatitis and cut steroid use
Disease control Recruiting nowBackground: Autoimmune hepatitis (AIH) is a rare chronic and lifelong liver disease. Untreated, disease progresses to end-stage cirrhosis and the focus of therapy is with immunosuppression. Current therapies are limited, not targeted, and associated with side effects that patient…
Phase 2 • Sponsor: University Health Network, Toronto • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Less may be more: smaller surgery for melanoma tested in 1,000-Patient trial
Disease control Recruiting nowThis clinical trial compares the effect of a narrow surgical excision (removal) to a wide excision for the treatment of adults with invasive cutaneous melanoma. Currently the standard of care is to take wide margins (boarder of healthy tissue surrounding the melanoma) when removi…
Sponsor: OHSU Knight Cancer Institute • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
Scientists probe why tezepelumab doesn't stop all asthma attacks
Knowledge-focused CompletedTezepelumab is a treatment that is approved by NICE (National Institute for Health and Care Excellence, https://www.nice.org.uk/) for patients with severe asthma, that remains poorly controlled despite high dose inhaled glucocorticosteroid medication. The goal of this observatio…
Sponsor: Guy's and St Thomas' NHS Foundation Trust • Aim: Knowledge-focused
Last updated Jul 01, 2026 00:00 UTC
-
Virtual reality could make depression therapy more immersive and effective
Disease control CompletedStudy Overview This study aims to evaluate the effectiveness of a newly developed Virtual Reality (VR) behavioral activation software program for individuals experiencing symptoms of depression. Behavioral activation is a well-established psychological approach that helps individ…
Sponsor: KTO Karatay University • Aim: Disease control
Last updated Jul 16, 2026 00:00 UTC
-
Could a stick of gum speed recovery after C-Section?
Symptom relief CompletedThis study was conducted as a randomized controlled trial to evaluate the effects of gum chewing in the early postpartum period on bowel function, postpartum comfort, and postpartum satisfaction in women. The sample consisted of 66 women, 33 in the experimental group and 33 in th…
Sponsor: Karabuk University • Aim: Symptom relief
Last updated Aug 15, 2026 00:00 UTC
-
Could a Two-Hormone combo beat standard thyroid treatment?
Disease control Recruiting nowHypothyroidism is a common condition, more frequent in females, associated with excess of cardiovascular risk and poor quality of life not completely abrogated by treatment with levothyroxine. There is an unmet need to define a safe, effective, and feasible regimen to be applied…
Phase 2/3 • Sponsor: UConn Health • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC
-
New mRNA flu vaccine shows promise in early human trial
Vaccine CompletedThe goal of this clinical trial is to evaluate the safety and immune responses of three different dose levels a self-amplifying RNA pandemic influenza vaccine (ARCT-2304) in adults. The key objectives of the study are: * To evaluate safety and reactogenicity of different dose le…
Phase 1/2 • Sponsor: Arcturus Therapeutics, Inc. • Aim: Vaccine
Last updated Sep 06, 2026 00:00 UTC
-
Weekly shot may boost growth in teens with dwarfism
Disease control Recruiting nowThe purpose of this clinical trial is to evaluate efficacy and safety of once weekly subcutaneous (SC) doses of navepegritide 100 μg/kg compared to placebo (inactive drug) in adolescents aged 12 to 18 years with Achondroplasia. What will be measured is Annualized Growth Velocity …
Phase 2 • Sponsor: Ascendis Pharma A/S • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
New hope for Crohn's: experimental drug aims to heal the gut
Disease control Recruiting nowThis is a phase 2, multinational, multicenter, randomized, double-blind, placebo-controlled, dose ranging study to evaluate the efficacy and safety of SAR441566 in adults with moderate to severe Crohn's Disease (CD). The primary objective of this study is to assess the efficacy o…
Phase 2 • Sponsor: Sanofi • Aim: Disease control
Last updated Jun 27, 2026 13:07 UTC
-
One-Day training may turn bystanders into helpers in dating violence
Knowledge-focused CompletedThis randomized controlled trial evaluated the effectiveness of a bystander intervention program for dating violence among nursing students. The study was conducted with second-year nursing students at Istanbul University-Cerrahpaşa Florence Nightingale Faculty of Nursing. A tota…
Sponsor: Istanbul University - Cerrahpasa • Aim: Knowledge-focused
Last updated Aug 19, 2026 00:00 UTC
-
New study tests peer support to ease transgender surgery journey
Symptom relief By invitation onlyThe STRIVE study is the first national randomized trial to focus on improving well-being, access to surgical care and other health outcomes for transgender and nonbinary (referred to as trans) people seeking genital gender-affirming surgery (GGAS). Trans people have gender identi…
Sponsor: Oregon Health and Science University • Aim: Symptom relief
Last updated Jun 27, 2026 11:01 UTC
-
New PET scan could predict breast cancer drug success before treatment
Diagnosis Recruiting nowThe objective of the study is to construct a noninvasive approach 68Ga-TTP PET/CT to detect the TROP2 expression of tumor lesions in patients with breast tumors and evaluate the efficacy of ADC drug therapy.
Sponsor: Peking University Cancer Hospital & Institute • Aim: Diagnosis
Last updated Aug 13, 2026 00:00 UTC
-
Suspension cords may give young volleyball players a jump on power
Knowledge-focused CompletedThe purpose of this study was to examine the effects of an 8-week TRX suspension training program on body composition, anaerobic power, and selected biomotor abilities in young male volleyball players. A total of 26 male volleyball players (aged 14-18 years) were randomly assign…
Sponsor: Bitlis Eren University • Aim: Knowledge-focused
Last updated Sep 05, 2026 00:00 UTC
-
New hope for muscle stiffness: experimental drug PGN-EDODM1 enters Mid-Stage trial
Disease control Recruiting nowThe purpose of this study is to learn about the effects of an investigational medicine, PGN-EDODM1, to see how safe and tolerable multiple administrations of PGN-EDODM1 are for people with myotonic dystrophy type 1 (DM1) compared to placebo.
Phase 2 • Sponsor: PepGen Inc • Aim: Disease control
Last updated Jul 31, 2026 00:00 UTC